| Dr Victor Ngachie, PHARM D | |
|
4203 Davenport St Nw, Washington, DC 20016-4549 | |
| (202) 364-0292 | |
| Not Available |
| Full Name | Dr Victor Ngachie |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 4203 Davenport St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013217728 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 100000088 (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Victor Ngachie, PHARM D 4203 Davenport St Nw, Washington, DC 20016-4549 Ph: (202) 364-0292 | Dr Victor Ngachie, PHARM D 4203 Davenport St Nw, Washington, DC 20016-4549 Ph: (202) 364-0292 |
News Archive
Checking his watch, Thomas B. Leonardi worked quickly through his dense defense of this nation's state-by-state approach to insurance regulation. This small New England state generates more insurance business than all but a half-dozen nations. He sided with consumer advocates in March at the National Association of Insurance Commissioners, helping to delay a federal regulation designed to protect fees for health insurance brokers. Advocates said the regulation would have driven up the costs of insurance to consumers.
SunLink Health Systems, Inc.(the "Company") today announced that in view of the unusual activity in the Company's stock, the New York Stock Exchange (NYSE) has contacted the Company in accordance with the NYSE's usual practice and requested that the Company respond by news release to the unusual activity.
Obese patients with high blood pressure and diabetes are at much higher risk for major complications following non-cardiac surgery compared to otherwise healthy obese patients and patients of normal weight.
Blood-glucose monitoring devices have revolutionized the management of diabetes by making it easy for ordinary individuals to test their glucose levels at home.
Molecular Detection Inc. (MDI), a company developing Detect-Ready tests designed to increase the speed and accuracy of infectious disease diagnosis, and life sciences and diagnostics distributor Eldan, a part on the Neopharm Group, today announced that they have entered into an exclusive agreement for distribution of MDI's Detect-Ready MRSA Panel in Israel and the Palestinian territories.
› Verified 9 days ago
Juliana O Anamelechi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 50 Irving St Nw, Washington, DC 20422 Phone: 202-745-8000 | |
Reine Kamtcheu Lienou, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7600 Georgia Ave Nw, Suite 323, Washington, DC 20012 Phone: 202-723-3060 Fax: 202-723-3065 | |
Gina Jin Lee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-4080 | |
Dr. Bruce Cofane, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 845 Bladensburg Rd Ne, Washington, DC 20002 Phone: 202-397-2600 | |
Mesay Abebe, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3100 14th St Nw, Washington, DC 20010 Phone: 202-777-3774 | |
Dr. Salome K Bwayo, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2300 4th St Nw, Washington, DC 20059 Phone: 202-806-7262 Fax: 202-806-4478 | |
Tracy Doney, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 110 Irving St Nw, Rm B147, Washington, DC 20010 Phone: 202-877-6747 |